NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Orphan Biovitrum A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
8,310
|
5,989
|
5,791 |
| Total assets |
55,027
|
45,503
|
45,222 |
| Current assets |
54,735
|
45,228
|
44,955 |
| Current liabilities |
7,283
|
6,619
|
12,638 |
| Equity capital |
47,744
|
77,766
|
65,170 |
| - share capital |
754
|
708
|
671 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.8%
|
170.9%
|
144.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
751.5%
|
683.3%
|
355.7% |
| Return on equity (ROE) |
17.4%
|
7.7%
|
8.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.